Primaquine in vivax malaria: An update and review on management issues

Malaria Journal

Volumn 10, Issue , 2011, Pages

  Fernando, Deepika ^a   Rodrigo, Chaturaka ^a   Rajapakse, Senaka ^a  

^a UNIVERSITY OF COLOMBO   (Sri Lanka)

Author keywords

Plasmodium vivax; Primaquine; Prophylaxis; Radical cure; Vivax Malaria

Indexed keywords

ARTEMISIN DERIVATIVE; ARTESUNATE; CHLOROQUINE; DOXYCYCLINE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; MEFLOQUINE; PLACEBO; PRIMAQUINE; TAFENOQUINE; AMINOQUINOLINE DERIVATIVE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE;

BODY WEIGHT; COST EFFECTIVENESS ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG EXPOSURE; DRUG TOLERABILITY; ENDEMIC DISEASE; GAMETOCYTE; GASTROINTESTINAL DISEASE; GENOTYPE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE DEFICIENCY; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HYPERSENSITIVITY; MALARIA FALCIPARUM; METHEMOGLOBINEMIA; PATIENT COMPLIANCE; PHENOTYPE; PLASMODIUM VIVAX MALARIA; PROPHYLAXIS; RECOMMENDED DRUG DOSE; RELAPSE; REVIEW; SINGLE DRUG DOSE; TREATMENT DURATION; TREATMENT FAILURE; CLINICAL TRIAL (TOPIC); DRUG RESISTANCE; GLYCOGEN STORAGE DISEASE TYPE 1; HEMOLYSIS; PARASITOLOGY; PATHOGENICITY; PATHOLOGY; PLASMODIUM VIVAX;

AMINOQUINOLINES; ANTIMALARIALS; ARTEMISININS; CHLOROQUINE; CLINICAL TRIALS AS TOPIC; DRUG RESISTANCE; GLYCOGEN STORAGE DISEASE TYPE I; HEMOLYSIS; HUMANS; MALARIA, VIVAX; PLASMODIUM VIVAX; PRIMAQUINE;

EID: 83155185461     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-10-351     Document Type: Review

References (92)

1. Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Hill DR, Baird JK, Parise ME, Lewis LS, Ryan ET, Magill AJ, Am J Trop Med Hyg 2006 75 402 415 16968913 (Pubitemid 46941297)
2. Primaquine revisited six decades after its discovery. Vale N, Moreira R, Gomes P, Eur J Med Chem 2009 44 937 953 10.1016/j.ejmech.2008.08.011 18930565
3. Clinical aspects of hemolysis in patients with P. vivax malaria treated with primaquine, in the Brazilian Amazon. Ramos WM Jr, Sardinha JF, Costa MR, Santana MS, Alecrim MG, Lacerda MV, Braz J Infect Dis 2010 14 410 412 10.1590/S1413-86702010000400017 20963329
4. Chemoprophylaxis in malaria: drugs, evidence of efficacy and costs. Fernando SD, Rodrigo C, Rajapakse S, Asian Pac J Trop Med 2011 4 4 330 336 10.1016/S1995-7645(11)60098-9 21771482
5. Primaquine for prophylaxis against malaria among nonimmune transmigrants in Irian Jaya, Indonesia. Baird JK, Fryauff DJ, Basri H, Bangs MJ, Subianto B, Purnomo, Wiady I, Leksana B, Masbar S, Richie TL, Jones TR, Tijitra E, Wignall FS, Hoffman SL, Am J Trop Med Hyg 1995 52 479 484 7611550
6. Randomized, parallel placebo-controlled trial of primaquine for malaria prophylaxis in Papua, Indonesia. Baird JK, Lacy MD, Basri H, Barcus MJ, Maguire JD, Bangs MJ, Gramzinski R, Sismadi P, Krisin, Ling J, Wiady I, Kusumaningsih M, Jones TR, Fryauff DJ, Hoffman SL, United States Naval Medical Research Unit 2 Clinical Trials Team, Clin Infect Dis 2001 33 1990 1997 10.1086/324085 11712091 (Pubitemid 33152392)
7. Randomised placebo-controlled trial of primaquine for prophylaxis of falciparum and vivax malaria. Fryauff DJ, Baird JK, Basri H, Sumawinata I, Purnomo, Richie TL, Ohrt CK, Mouzin E, Church CJ, Richards AL, Subianto B, Sandjaja B, Wignall FS, Hoffman SL, Lancet 1995 346 1190 1193 10.1016/S0140-6736(95)92898-7 7475658
8. Double-blind, randomized, placebo-controlled assessment of chloroquine/primaquine prophylaxis for malaria in nonimmune Colombian soldiers. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, Berman J, Clin Infect Dis 1999 29 199 201 10.1086/520154 10433587 (Pubitemid 29336826)
9. Primaquine as prophylaxis for malaria for nonimmune travelers: A comparison with mefloquine and doxycycline. Schwartz E, Regev-Yochay G, Clin Infect Dis 1999 29 1502 1506 10.1086/313527 10585803 (Pubitemid 30022748)
10. Malaria in a nonimmune population after extended chloroquine or primaquine prophylaxis. Fryauff DJ, Baird JK, Purnomo, Awalludin M, Jones T, Subianto B, Richie TL, Tjitra E, Wignall FS, Hoffman SL, Am J Trop Med Hyg 1997 56 137 140 9080870 (Pubitemid 27131670)
11. Primaquine prophylaxis against malaria in nonimmune Colombian soldiers: efficacy and toxicity. A randomized, double-blind, placebo-controlled trial. Soto J, Toledo J, Rodriquez M, Sanchez J, Herrera R, Padilla J, Berman J, Ann Intern Med 1998 129 241 244 9696733 (Pubitemid 28377515)
12. Plasmodium vivax relapses after 5 days of primaquine treatment, in some industrial complexes of India. Dua VK, Sharma VP, Ann Trop Med Parasitol 2001 95 655 659 10.1080/00034980120103225 11784418 (Pubitemid 33116499)
13. Radical curative efficacy of five-day regimen of primaquine for treatment of Plasmodium vivax malaria in India. Yadav RS, Ghosh SK, J Parasitol 2002 88 1042 1044 12435158 (Pubitemid 35278764)
14. Prevention of Plasmodium vivax malaria recurrence: efficacy of the standard total dose of primaquine administered over 3 days. Carmona-Fonseca J, Maestre A, Acta Trop 2009 112 188 192 10.1016/j.actatropica.2009.07.024 19653988
15. Primaquine for preventing relapses in people with Plasmodium vivax malaria. Galappaththy GN, Omari AA, Tharyan P, Cochrane Database Syst Rev 2007 D004389
16. In-vivo sensitivity of Plasmodium vivax isolates from Rond nia (Western Amazon region, Brazil) to regimens including chloroquine and primaquine. Villalobos-Salcedo JM, Tada MS, Kimura E, Menezes MJ, Pereira da Silva LH, Ann Trop Med Parasitol 2000 94 749 758 10.1080/00034980020027960 11214093 (Pubitemid 32102485)
17. Efficacy of a five-day course of primaquine in preventing relapses in Plasmodium vivax malaria - a pilot study. Fernandopulle BM, Weeraratne CL, Weerasuriya K, Karunaweera ND, Ceylon Med J 2003 48 32 12795021
18. Resistance to therapies for infection by Plasmodium vivax. Baird JK, Clin Microbiol Rev 2009 22 508 534 10.1128/CMR.00008-09 19597012
19. Plasmodium vivax malaria relapses after primaquine prophylaxis. Reddy P, Flaherty JP, Emerg Infect Dis 2006 12 1795 1796 10.3201/eid1211.060613 17283643 (Pubitemid 44674268)
20. Efficacy of primaquine regimens for primaquine-resistant Plasmodium vivax malaria in Thailand. Wilairatana P, Silachamroon U, Krudsood S, Singhasivanon P, Treeprasertsuk S, Bussaratid V, Phumratanaprapin W, Srivilirit S, Looareesuwan S, Am J Trop Med Hyg 1999 61 973 977 10674681 (Pubitemid 30084124)
21. Combined chloroquine and primaquine resistant Plasmodium vivax malaria in a patient returning from India. Van den Abbeele K, Van den Enden E, Van den Ende J, Ann Soc Belg Med Trop 1995 75 73 74 7794065
22. Subdoses of primaquine in overweight patients and malaria vivax relapses: report of two cases in the Federal District, Brazil. Santos JB, Luz FC, Deckers FA, Tauil PL, Rev Soc Bras Med Trop 2010 43 749 750 10.1590/S0037- 86822010000600033 21181040
23. World Health Organization, Guidelines for the treatment of malaria Geneva: WHO Press 2 2010
24. Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria. Pukrittayakamee S, Chotivanich K, Chantra A, Clemens R, Looareesuwan S, White NJ, Antimicrob Agents Chemother 2004 48 1329 1334 10.1128/AAC.48.4.1329-1334.2004 15047537 (Pubitemid 38405489)
25. Plasmodium falciparum gametocyte carriage is associated with subsequent Plasmodium vivax relapse after treatment. Lin JT, Bethell D, Tyner SD, Lon C, Shah NK, Saunders DL, Sriwichai S, Khemawoot P, Kuntawunggin W, Smith BL, Noedl H, Schaecher K, Socheat D, Se Y, Meshnick SR, Fukuda MM, PLoS One 2011 6 18716 10.1371/journal.pone.0018716 21533092
26. Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trial. Smithuis F, Kyaw MK, Phe O, Win T, Aung PP, Oo AP, Naing AL, Nyo MY, Myint NZ, Imwong M, Ashley E, Lee SJ, White NJ, Lancet Infect Dis 2010 10 673 681 10.1016/S1473-3099(10)70187-0 20832366
27. Plasmodium vivax recurrence following falciparum and mixed species malaria: risk factors and effect of antimalarial kinetics. Douglas NM, Nosten F, Ashley EA, Phaiphun L, van Vugt M, Clin Infect Dis 2011 52 612 620 10.1093/cid/ciq249 21292666
28. British National Formulary., British Medical Association, 2009
29. Frequency of malaria and glucose-6-phosphate dehydrogenase deficiency in Tajikistan. Rebholz CE, Michel AJ, Maselli DA, Saipphudin K, Wyss K, Malar J 2006 5 51 10.1186/1475-2875-5-51 16780577 (Pubitemid 44211708)
30. Beutler E, Hemolytic Anemia in Disorders of Red Cell Metabolism New York: Platinum Press 1978
31. Prevalence and clinical presentation of glucose-6-phosphate dehydrogenase deficiency in Pakistani Pathan and Afghan refugee communities in Pakistan; implications for the use of primaquine in regional malaria control programmes. Bouma MJ, Goris M, Akhtar T, Khan N, Kita E, Trans R Soc Trop Med Hyg 1995 89 62 64 10.1016/0035-9203(95)90661-4 7747310
32. Glucose-6-phosphate dehydrogenase deficiency. Beutler E, N Engl J Med 1991 324 169 174 10.1056/NEJM199101173240306 1984194
33. X-linked G6PD deficiency protects hemizygous males but not heterozygous females against severe malaria. Guido A, Fairhurst RM, Doumbo OK, Wellems TE, Diallo DA, PLoS Med 2007 4 66 10.1371/journal.pmed.0040066 17355169 (Pubitemid 46495319)
34. Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria. Ruwende C, Khoo SC, Snow RW, Nature 1995 376 246 249 10.1038/376246a0 7617034
35. The impact of phenotypic and genotypic G6PD deficiency on risk of Plasmodium vivax infection: a case-control study amongst Afghan refugees in Pakistan. Leslie T, Briceno M, Mayan I, Mohammed N, Klinkenberg E, Sibley CH, Whitty CJ, Rowland M, PLoS Med 2010 7 1000283 10.1371/journal.pmed.1000283 20520804
36. Positively selected G6PD-Mahidol mutation reduces Plasmodium vivax density in Southeast Asians. Louicharoen C, Patin E, Paul R, Nuchprayoon I, Witoonpanich B, Science 2009 326 1546 1549 10.1126/science.1178849 20007901
37. The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E, Blood Cells Mol Dis 2009 42 267 278 10.1016/j.bcmd.2008.12.005 19233695
38. An update on the prevalence of glucose-6-phosphate dehydrogenase deficiency and neonatal jaundice in Tehran neonates. Abolghasemi H, Mehrani H, Amid A, Clin Biochem 2004 37 241 244 10.1016/j.clinbiochem.2003.11.010 14972648 (Pubitemid 38221574)
39. Population genetics research in the Lerik region of Azerbaijan. Mukhtarov Z, Alieva KA, Rasulov LM, Tsitol Genet 2000 4 22 29
40. Mitigation of the hemolytic effect of primaquine and enhancement of its action against erythrocytic forms of the Chesson strain of Plasmodium vivax by intermittent regimens of drug administration. A preliminary report. Alving AS, Johnson CF, Tarlov AR, Brewer GJ, Kellermeyer RW, Carson PE, Bull World Health Organ 1960 22 621 13793053
41. The haemolytic effect of various regimens of primaquine with chloroquine in American Negroes with G6PD deficiency and the lack of an effect of various antimalarial suppressive agents on erythrocyte metabolism. Brewer GJ, Zarafonetis CJ, Bull World Health Organ 1967 36 303 308 4864652
42. A randomised trial of an eight-week, once weekly primaquine regimen to prevent relapse of Plasmodium vivax in Northwest Frontier Province, Pakistan. Leslie T, Mayan I, Mohammed N, Erasmus P, Kolaczinski J, Whitty CJ, Rowland M, PLoS One 2008 3 2861 10.1371/journal.pone.0002861 18682739
43. The use of primaquine in malaria infected patients with red cell glucose-6-phosphate dehydrogenase (G6PD) deficiency in Myanmar. Myat Phone K, Myint O, Aung N, Aye Lwin H, Southeast Asian J Trop Med Public Health 1994 25 710 713 7667719
44. Chloroquine sensitivity of Plasmodium vivax in Thailand. Looareesuwan S, Wilairatana P, Krudsood S, Treeprasertsuk S, Singhasivanon P, Bussaratid V, Chokjindachai W, Viriyavejakul P, Chalermrut K, Walsh DS, White J, Ann Trop Med Parasitol 1999 93 225 230 10.1080/00034989958474 10562823 (Pubitemid 29355870)
45. The course of primaquine-induced haemolysis in G-6-PD-deficient Thais. Charoenlarp P, Areekul S, Pholpothi T, Harinasuta T, J Med Assoc Thai 1973 56 392 397 4805904
46. Special modifications of the fluorescent screening method for glucose-6-phosphate dehydrogenase deficiency. Beutler E, Mitchell M, Blood 1968 32 816 818 4386875
47. Methemoglobinemia and adverse events in Plasmodium vivax malaria patients associated with high doses of primaquine treatment. Carmona-Fonseca J, Alvarez G, Maestre A, Am J Trop Med Hyg 2009 80 188 193 19190211
48. Toxicity of primaquine in caucasians. Clayman CB, Arnold J, Hockwold RS, Yount EH, Edgecomb JH, Alving AS, JAMA 1952 149 1563 1568 10.1001/jama.1952. 72930340022010b
49. Methaemoglobin levels in soldiers receiving antimalarial drugs. Sietsma A, Naughton MA, Harley JD, Med J Aust 1971 1 473 475 5552440
50. [Association of methemoglobinemia and glucose-6-phosphate dehydrogenase deficiency in malaria patients treated with primaquine] (in Portuguese). Santana MS, da Rocha MA, Arcanjo AR, Sardinha JF, Alecrim WD, Alecrim MG, Rev Soc Bras Med Trop 2007 40 533 536 10.1590/S0037-86822007000500008 17992408 (Pubitemid 350099291)
51. [Methemoglobinemia in patients with Plasmodium vivax receiving oral therapy with primaquine] (in Portuguese). Ferreira ME, Gomes Mdo S, Vieira JL, Rev Soc Bras Med Trop 2011 44 113 115 10.1590/S0037-86822011000100026 21340422
52. Primaquine-induced differential gene expression analysis in mice liver using DNA microarrays. Noel S, Sharma S, Shanker R, Rath SK, Toxicology 2007 239 96 107 10.1016/j.tox.2007.06.098 17686563 (Pubitemid 47284616)
53. Poor response to primaquine in two cases of Plasmodium vivax malaria from Guatemala. Gascon J, Gomez Arce JE, Menendez C, Valls ME, Corachan M, Trop Geogr Med 1994 46 32 33 8165734
54. Treatment of vivax malaria in an endemic area on the western border of Thailand. Luxemburger C, Van Vugt M, Jonathan S, McGready R, Looaresuwan S, White NJ, Nosten F, Trans R Soc Trop Med Hyg 1999 93 433 438 10.1016/S0035-9203(99)90149-9 10674098 (Pubitemid 29405879)
55. Blood stage antimalarial efficacy of primaquine in Plasmodium vivax malaria. Pukrittayakamee S, Vanijanonta S, Chantra A, Clemens R, White NJ, J Infect Dis 1994 169 932 935 10.1093/infdis/169.4.932 8133114 (Pubitemid 24102139)
56. Randomized trial of 3-dose regimens of tafenoquine (WR238605) versus low-dose primaquine for preventing Plasmodium vivax malaria relapse. Walsh DS, Wilairatana P, Tang DB, Heppner DG, Brewer TG, Krudsood S, Silachamroon U, Phumratanaprapin W, Siriyanonda D, Looareesuwan S, Clin Infect Dis 2004 39 1095 1103 10.1086/424508 15486831 (Pubitemid 40169305)
57. A comparison of two short-course primaquine regimens for the treatment and radical cure of Plasmodium vivax malaria in Thailand. Pukrittayakamee S, Imwong M, Chotivanich K, Singhasivanon P, Day NP, White NJ, Am J Trop Med Hyg 2010 82 542 547 10.4269/ajtmh.2010.09-0428 20348496
58. Directly-observed therapy (DOT) for the radical 14-day primaquine treatment of Plasmodium vivax malaria on the Thai-Myanmar border. Takeuchi R, Lawpoolsri S, Imwong M, Kobayashi J, Kaewkungwal J, Pukrittayakamee S, Puangsa-art S, Thanyavanich N, Maneeboonyang W, Day NP, Singhasivanon P, Malar J 2010 9 308 10.1186/1475-2875-9-308 21040545
59. Regional differences in the response of Plasmodium vivax malaria to primaquine as anti-relapse therapy. Goller JL, Jolley D, Ringwald P, Biggs BA, Am J Trop Med Hyg 2007 76 203 207 17297026 (Pubitemid 351627764)
60. A consideration of primaquine dose adjustment for radical cure of Plasmodium vivax malaria. Schwartz E, Regev-Yochay G, Kurnik D, Am J Trop Med Hyg 2000 62 393 395 11037784
61. Failure of combined chloroquine and high-dose primaquine therapy for Plasmodium vivax malaria acquired in Guyana, South America. Phillips EJ, Keystone JS, Kain KC, Clin Infect Dis 1996 23 1171 1173 10.1093/clinids/23.5. 1171 8922821 (Pubitemid 126782788)
62. Plasmodium vivax infections in U.S. Army troops: failure of primaquine to prevent relapse in studies from Somalia. Smoak BL, DeFraites RF, Magill AJ, Kain KC, Wellde BT, Am J Trop Med Hyg 1997 56 231 234 9080885 (Pubitemid 27131685)
63. Efficacy of a 14-day primaquine regimen in preventing relapses in patients with Plasmodium vivax malaria in Mumbai, India. Rajgor DD, Gogtay NJ, Kadam VS, Kamtekar KD, Dalvi SS, Chogle AR, Aigal U, Bichile LS, Kain KC, Kshirsagar NA, Trans R Soc Trop Med Hyg 2003 97 438 440 10.1016/S0035-9203(03) 90082-4 15259476 (Pubitemid 39186028)
64. Management of vivax malaria with low sensitivity to primaquine. Ajdukiewicz KM, Ong EL, J Infect 2007 54 209 211 10.1016/j.jinf.2006.05.008 16860871 (Pubitemid 46238170)
65. Therapeutic efficacy of chloroquine and chloroquine plus primaquine for the treatment of Plasmodium vivax in Ethiopia. Yeshiwondim AK, Tekle AH, Dengela DO, Yohannes AM, Teklehaimanot A, Acta Trop 2010 113 105 113 10.1016/j.actatropica.2009.10.001 19835832
66. Diagnostic and therapeutic pitfalls associated with primaquine-tolerant Plasmodium vivax. Spudick JM, Garcia LS, Graham DM, Haake DA, J Clin Microbiol 2005 43 978 981 10.1128/JCM.43.2.978-981.2005 15695723 (Pubitemid 40256077)
67. Adherence to 7-day primaquine treatment for the radical cure of P. vivax in the Peruvian Amazon. Grietens KP, Soto V, Erhart A, Ribera JM, Toomer E, Tenorio A, Montalvo TG, Rodriguez H, Cuentas AL, D'Alessandro U, Gamboa D, Am J Trop Med Hyg 2010 82 1017 1023 10.4269/ajtmh.2010.09-0521 20519594
68. Establishment of an in vitro assay for assessing the effects of drugs on the liver stages of Plasmodium vivax malaria. Chattopadhyay R, Velmurugan S, Chakiath C, Andrews Donkor L, Milhous W, Barnwell JW, Collins WE, Hoffman SL, PLoS One 2010 5 14275 10.1371/journal.pone.0014275 21151554
69. Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia. Orjuela-Sanchez P, da Silva NS, da Silva-Nunes M, Ferreira MU, Am J Trop Med Hyg 2009 81 961 968 10.4269/ajtmh.2009.09-0337 19996423
70. Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites. Imwong M, Snounou G, Pukrittayakamee S, Tanomsing N, Kim JR, Nandy A, Guthmann JP, Nosten F, Carlton J, Looareesuwan S, Nair S, Sudimack D, Day NPJ, Anderson TJC, White NJ, J Infect Dis 2007 195 927 933 10.1086/512241 17330781 (Pubitemid 46452096)
71. Primaquine therapy for malaria. Baird JK, Hoffman SL, Clin Infect Dis 2004 39 1336 1345 10.1086/424663 15494911 (Pubitemid 39458520)
72. Potentiation of the curative action of primaquine in vivax malaria by quinine and chloroquine. Alving AS, Arnold J, Hockwald RS, Clayman C, Dern RJ, Beutler E, Flanagan CL, J Lab Clin Med 1955 46 301 306 13242948
73. Primaquine, SN 13272: a new curative agent in vivax malaria: a preliminary report. Edgcomb JH, Arnold J, Yount EHJ, Alving AS, Eichelberger L, J National Malaria Soc 1950 9 285 292
74. Plasmodium vivax Chesson strain. Ehrman FC, Ellis JM, Young MD, Science 1944 101 377
75. Plasmodium vivax resistance to chloroquine- Rieckmann KH, Davis DR, Hutton DC, Lancet 1989 2 1183 1184 2572903 (Pubitemid 19275451)
76. Resistance to chloroquine by Plasmodium vivax in Irian Jaya, Indonesia. Baird JK, Basri H, Purnomo, Bangs MJ, Subianto B, Patchen LC, Hoffman SL, Am J Trop Med Hyg 1991 44 547 552 1676566
77. Emergence of chloroquine-resistant Plasmodium vivax in Myanmar (Burma). Myat-Phone-Kyaw, Myint-Oo, Myint-Lwin, Thaw-Zin, Kyin-Hla-Aye, Nwe-Nwe-Yin, Trans R Soc Trop Med Hyg 1993 87 687 10.1016/0035-9203(93)90294-Z 8296378
78. Chloroquine resistant Plasmodium vivax malaria in India. Dua VK, Kar PK, Sharma VP, Trop Med Int Health 1996 1 816 819 8980595 (Pubitemid 27010563)
79. Efficacy of chloroquine in the treatment of Plasmodium vivax malaria in Turkey. Kurcer MA, Simsek Z, Zeyrek FY, Atay S, Celik H, Kat I, Topluoglu S, Ann Trop Med Parasitol 2004 98 447 451 10.1179/000349804225021343 15257793 (Pubitemid 38951677)
80. Chloroquine-resistant Plasmodium vivax malaria in Debre Zeit, Ethiopia. Teka H, Petros B, Yamuah L, Tesfaye G, Elhassan I, Muchohi S, Kokwaro G, Aseffa A, Engers H, Malar J 2008 7 220 228 10.1186/1475-2875-7-220 18959774
81. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Alecrim M, das G, Alecrim W, Macêdo V, Rev Soc Bras Med Trop 1999 32 67 68 9927829 (Pubitemid 29006271)
82. Chloroquine-resistant Plasmodium vivax malaria in Peru. Ruebush TK, Zegarra J, Cairo J, Andersen EM, Green M, Pillai DR, Marquĩo W, Huilca M, Arévalo E, Garcia C, Solari L, Kain KC, Am J Trop Med Hyg 2003 69 548 552 14695094 (Pubitemid 38248258)
83. Plasmodium vivax clinically resistant to chloroquine in Colombia. Soto J, Toledo J, Gutierrez P, Luzz M, Llinas N, Cedẽo N, Dunne M, Berman J, Am J Trop Med Hyg 2000 65 90 93
84. Clinical efficacy of chloroquine versus artemether-lumefantrine for Plasmodium vivax treatment in Thailand. Krudsood S, Tangpukdee N, Muangnoicharoen S, Thanachartwet V, Luplertlop N, Srivilairit S, Wilairatana P, Kano S, Ringwald P, Looareesuwan S, Korean J Parasitol 2007 45 111 114 10.3347/kjp.2007.45.2.111 17570973
85. Therapeutic efficacy of artesunate in Plasmodium vivax malaria in Thailand. Hamedi Y, Safa O, Zare S, Tan-ariya P, Kojima S, Looareesuwan S, Southeast Asian J Trop Med Public Health 2004 35 570 574 15689068 (Pubitemid 39486423)
86. High-dose primaquine regimens against relapse of Plasmodium vivax malaria. Krudsood S, Tangpukdee N, Wilairatana P, Phophak N, Baird JK, Brittenham GM, Looareesuwan S, Am J Trop Med Hyg 2008 78 736 740 18458306 (Pubitemid 351845129)
87. Vivax malaria: preliminary observations following a shorter course of treatment with artesunate plus primaquine. Dao NV, Cuong BT, Ngoa ND, Thuy le TT, The ND, Duy DN, Dai B, Thanh NX, Chavchich M, Rieckmann KH, Edstein MD, Trans R Soc Trop Med Hyg 2007 101 534 539 10.1016/j.trstmh.2007.01.003 17368694 (Pubitemid 46613462)
88. Clinical trial of oral artesunate with or without high-dose primaquine for the treatment of vivax malaria in Thailand. Silachamroon U, Krudsood S, Treeprasertsuk S, Wilairatana P, Chalearmrult K, Mint HY, Maneekan P, White NJ, Gourdeuk VR, Brittenham GM, Looareesuwan S, Am J Trop Med Hyg 2003 69 14 18 12932090
89. Artemisinin-based combination therapy for treating uncomplicated Plasmodium vivax malaria. Sinclair D, Gogtay N, Brand F, Olliaro P, Cochrane Database Syst Rev 2011 D008492
90. Targeting the hypnozoite reservoir of Plasmodium vivax: the hidden obstacle to malaria elimination. Wells TN, Burrows JN, Baird JK, Trends Parasitol 2010 26 145 151 10.1016/j.pt.2009.12.005 20133198
91. The efficacy and tolerability of three different regimens of tafenoquine versus primaquine for post-exposure prophylaxis of Plasmodium vivax malaria in the Southwest Pacific. Elmes NJ, Nasveld PE, Kitchener SJ, Kocisko DA, Edstein MD, Trans R Soc Trop Med Hyg 2008 102 1095 1101 10.1016/j.trstmh.2008.04.024 18541280
92. Tafenoquine for the treatment of recurrent Plasmodium vivax malaria. Kitchener S, Nasveld P, Edstein MD, Am J Trop Med Hyg 2007 76 494 496 17360873 (Pubitemid 351627742)